Change Password

CLEAR

Set a new password

New password

Confirm password

Repatha^® (evolocumab) is subject to additional monitoring. Adverse events should be reported. Reporting forms and information can be found:

Adverse events should also be reported to Amgen Limited on:

+44 (0) 1223 436 441

If you think there may be a defect or quality issue with the Amgen product you have received, please provide us with the details via phone call:

+44 (0) 1223 436 441

×